why choose us

Clinical Trials Search

Showing 10,700 of 132,366 result(s)
Sleep and Vascular Health Study

Status: Completed

Condition: Sleep

Interventions: Participants will extend their time in bed by one hour for 2 weeks while being monitored.

Date: 2023-06-08

Limited-duration Teclistamab

Status: Completed

Condition: Myeloma Multiple

Interventions: After stopping teclistamab, participants will be monitored monthly by standard serum paraprotein studies for disease progression.
Participants wi

Date: 2023-06-08

Coaching for Advanced Practice Providers

Status: Completed

Condition: Burnout, Professional

Interventions: A hybrid asynchronous-synchronous program.
The synchronous part has two weekly recorded live group coaching calls for four months.
The async

Date: 2023-06-08

A Study of a Dietary Supplement in Breastfeeding Mothers (WellFed)

Status: COMPLETED

Condition: Dietary Habits

Interventions: Supplement taken daily for 4 weeks.

Date: 2023-06-08

Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney Injury After Solid Organ Transplant

Status: COMPLETED

Condition: Acute Kidney Injury

Interventions: Early biomarker of AKI

Date: 2023-06-08

A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

Status: COMPLETED

Condition: Melanoma

Interventions: ABP 206 will be given intravenously over a period of 30 minutes, every 4 weeks (Q4W) for a total of 12 months.

Date: 2023-06-08

Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo

Status: COMPLETED

Condition: Hypoparathyroidism

Interventions: Oral tablets

Date: 2023-06-08

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Status: COMPLETED

Condition: Pulmonary Embolism

Interventions: Use of Aventus Thrombectomy System to treat pulmonary embolism

Date: 2023-06-08

Topical Ruxolitinib Evaluation in Chronic Hand Eczema

Status: COMPLETED

Condition: Hand Eczema

Interventions: Ruxolitinib cream is a topical formulation applied as a thin film to affected areas.

Date: 2023-06-07

Usefulness of Continuous Glucose Monitoring in MODY Diagnosis

Status: COMPLETED

Condition: Type 1 Diabetes

Interventions:

Use of Intermittenly scanned continuous glucose monitoring (FreeStyle Libre) and meeting the glycometric data criteria:

  • Time in range 70

    Date: 2023-06-07